ArriVent BioPharma (AVBP) Stock: Why It Rose
Updated Oct 19, 2026, 4:00 PM ET · closing price
- Closed at $17.94, +7.68% vs the prior close of $16.66.
- Volume 1.01M shares, 0.9x its 50-day average.
- New SEC filings: 8-K (Oct 19, 2026).
- No new insider buys or sales reported since the prior session.
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)
AVBP jumps 7.7% to $17.94. Closed at $17.94, +7.68% vs the prior close of $16.66. Day range $16.73–$18.14, opened at $16.82.
AVBP daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — AVBP jumps 7.7% to $17.94
- Closed at $17.94, +7.68% vs the prior close of $16.66. Day range $16.73–$18.14, opened at $16.82.
- Volume was 1.01M shares, 0.9x its 50-day average of 1.14M.
- Price is -33.7% vs its 50-day average ($27.08) and -33.8% vs its 200-day average ($27.10).
- 52-week range $11.36–$35.83; today's close sits at 27% of that range, 49.9% below the 52-week high.
- SEC filings that day: 8-K.
Oct 16, 2026 — AVBP dips 0.8% to $16.66
- Closed at $16.66, -0.77% vs the prior close of $16.79. Day range $16.49–$17.23, opened at $16.86.
- Volume was 1.33M shares, 1.2x its 50-day average of 1.12M.
- Price is -39.0% vs its 50-day average ($27.33) and -38.5% vs its 200-day average ($27.11).
- 52-week range $11.36–$35.83; today's close sits at 22% of that range, 53.5% below the 52-week high.
Oct 15, 2026 — AVBP jumps 3.6% to $16.79
- Closed at $16.79, +3.64% vs the prior close of $16.20. Day range $15.97–$16.91, opened at $16.40.
- Volume was 814.90K shares, 0.7x its 50-day average of 1.11M.
- Price is -39.2% vs its 50-day average ($27.62) and -38.1% vs its 200-day average ($27.13).
- 52-week range $11.36–$35.83; today's close sits at 22% of that range, 53.1% below the 52-week high.
Oct 14, 2026 — AVBP rises 0.7% to $16.20
- Closed at $16.20, +0.68% vs the prior close of $16.09. Day range $15.26–$16.61, opened at $16.06.
- Volume was 1.59M shares, 1.5x its 50-day average of 1.09M.
- Price is -41.9% vs its 50-day average ($27.90) and -40.3% vs its 200-day average ($27.15).
- 52-week range $11.36–$35.83; today's close sits at 20% of that range, 54.8% below the 52-week high.
Oct 13, 2026 — AVBP dips 2.2% to $16.09 on 1.9x normal volume
- Closed at $16.09, -2.25% vs the prior close of $16.46. Day range $15.95–$16.72, opened at $16.28.
- Volume was 1.97M shares, 1.9x its 50-day average of 1.06M — unusually heavy trading.
- Price is -42.9% vs its 50-day average ($28.20) and -40.8% vs its 200-day average ($27.18).
- 52-week range $11.36–$35.83; today's close sits at 19% of that range, 55.1% below the 52-week high.
- SEC filings that day: 8-K.
Oct 12, 2026 — AVBP dips 1.6% to $16.46
- Closed at $16.46, -1.61% vs the prior close of $16.73. Day range $16.26–$16.78, opened at $16.57.
- Volume was 1.34M shares, 1.3x its 50-day average of 1.04M.
- Price is -42.2% vs its 50-day average ($28.47) and -39.5% vs its 200-day average ($27.21).
- 52-week range $11.36–$35.83; today's close sits at 21% of that range, 54.1% below the 52-week high.
Oct 9, 2026 — AVBP ends flat (+0.1%) to $16.73
- Closed at $16.73, +0.12% vs the prior close of $16.71. Day range $16.49–$17.76, opened at $16.59.
- Volume was 1.73M shares, 1.7x its 50-day average of 1.01M.
- Price is -41.8% vs its 50-day average ($28.74) and -38.6% vs its 200-day average ($27.24).
- 52-week range $11.36–$35.83; today's close sits at 22% of that range, 53.3% below the 52-week high.
Oct 8, 2026 — AVBP dips 1.1% to $16.71 on 2.2x normal volume
- Closed at $16.71, -1.07% vs the prior close of $16.89. Day range $15.78–$16.91, opened at $16.62.
- Volume was 2.15M shares, 2.2x its 50-day average of 974.46K — unusually heavy trading.
- Price is -42.4% vs its 50-day average ($29.02) and -38.7% vs its 200-day average ($27.27).
- 52-week range $11.36–$35.83; today's close sits at 22% of that range, 53.4% below the 52-week high.
Oct 7, 2026 — AVBP jumps 11.9% to $16.89 on 4.8x normal volume
- Closed at $16.89, +11.93% vs the prior close of $15.09. Day range $14.97–$17.34, opened at $15.24.
- Volume was 4.33M shares, 4.8x its 50-day average of 904.18K — unusually heavy trading.
- Price is -42.3% vs its 50-day average ($29.29) and -38.1% vs its 200-day average ($27.29).
- 52-week range $11.36–$35.83; today's close sits at 23% of that range, 52.9% below the 52-week high.
Oct 6, 2026 — AVBP slides 47.0% to $15.09, a 52-week low on 37.6x normal volume
- Closed at $15.09, -46.98% vs the prior close of $28.46. Day range $11.36–$15.79, opened at $12.09.
- Volume was 19.74M shares, 37.6x its 50-day average of 524.52K — unusually heavy trading.
- Price is -48.9% vs its 50-day average ($29.55) and -44.8% vs its 200-day average ($27.32).
- 52-week range $11.36–$35.83; today's close sits at 15% of that range, 57.9% below the 52-week high.
- SEC filings that day: 8-K.
Oct 5, 2026 — AVBP rises 0.7% to $28.46
- Closed at $28.46, +0.67% vs the prior close of $28.27. Day range $27.02–$28.70, opened at $28.00.
- Volume was 494.80K shares, 0.9x its 50-day average of 524.12K.
- Price is -4.7% vs its 50-day average ($29.85) and +4.1% vs its 200-day average ($27.35).
- 52-week range $17.00–$35.83; today's close sits at 61% of that range, 20.6% below the 52-week high.
Oct 2, 2026 — AVBP dips 2.3% to $28.27
- Closed at $28.27, -2.28% vs the prior close of $28.93. Day range $27.80–$29.33, opened at $29.26.
- Volume was 507.60K shares, 1.0x its 50-day average of 520.21K.
- Price is -5.5% vs its 50-day average ($29.91) and +3.5% vs its 200-day average ($27.32).
- 52-week range $17.00–$35.83; today's close sits at 60% of that range, 21.1% below the 52-week high.
AVBP bull case vs bear case (from the data)
- No clear positive signal in the price trend, filings or insider data right now.
- Price is -33.7% vs its 50-day average — short-term trend is down.
- Price is -33.8% vs its 200-day average — below the long-term trend line.
- Latest fiscal-year net income: loss of $166.31M.
- Insider selling outweighs buying: 8 sales vs 0 open-market buys among the 8 most recent reported insider trades (Form 4, last 12 months).
- Share count up 21.5% in a year (dilution).
- High volatility: average daily move of 4.9% over 20 sessions.
AVBP latest news & SEC filings
Every SEC filing by or about AVBP in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 19, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Oct 13, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Oct 8, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$49.89M (prior year -$31.40M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$1.05 (prior year -$0.90) (loss widened vs Jun 30, 2025)
Aug 12, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 27, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Things to know before you trade AVBP
- Last results release: Aug 12, 2026 (8-K Item 2.02). Previous ones: May 11, 2026, Mar 5, 2026, Nov 10, 2025. Based on that rhythm, the next report is likely around Nov 11, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 4.93% (largest 47.0%). That is a volatile stock.
- Liquidity: about 2.15M shares (≈$38.55M) trade per day on average.
- 52-week position: $17.94 vs a range of $11.36–$35.83 (27% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 8 sales; latest: Advisors, Ltd. Hhlr sold 555,555 shares on Dec 10, 2025.
- Latest filings: 8-K Oct 19, 2026; 8-K Oct 13, 2026; 8-K Oct 6, 2026.
- Share count: 49.31M shares outstanding (Aug 10, 2026), +21.5% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
AVBP market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 16.82 | 18.14 | 16.73 | 17.94 | 1.01M |
| Oct 16, 2026 | 16.86 | 17.23 | 16.49 | 16.66 | 1.33M |
| Oct 15, 2026 | 16.40 | 16.91 | 15.97 | 16.79 | 814.90K |
| Oct 14, 2026 | 16.06 | 16.61 | 15.26 | 16.20 | 1.59M |
| Oct 13, 2026 | 16.28 | 16.72 | 15.95 | 16.09 | 1.97M |
| Oct 12, 2026 | 16.57 | 16.78 | 16.26 | 16.46 | 1.34M |
| Oct 9, 2026 | 16.59 | 17.76 | 16.49 | 16.73 | 1.73M |
| Oct 8, 2026 | 16.62 | 16.91 | 15.78 | 16.71 | 2.15M |
| Oct 7, 2026 | 15.24 | 17.34 | 14.97 | 16.89 | 4.33M |
| Oct 6, 2026 | 12.09 | 15.79 | 11.36 | 15.09 | 19.74M |
| Oct 5, 2026 | 28.00 | 28.70 | 27.02 | 28.46 | 494.80K |
| Oct 2, 2026 | 29.26 | 29.33 | 27.80 | 28.27 | 507.60K |
| Oct 1, 2026 | 29.99 | 30.64 | 28.81 | 28.93 | 591.80K |
| Sep 30, 2026 | 29.69 | 30.90 | 29.65 | 30.28 | 712.50K |
| Sep 29, 2026 | 29.30 | 30.05 | 28.80 | 29.54 | 780.00K |
| Sep 28, 2026 | 28.38 | 29.90 | 28.02 | 29.30 | 1.02M |
| Sep 25, 2026 | 30.16 | 30.55 | 28.43 | 28.45 | 653.20K |
| Sep 24, 2026 | 29.94 | 30.51 | 29.24 | 30.10 | 609.00K |
| Sep 23, 2026 | 30.32 | 31.49 | 29.84 | 30.30 | 1.21M |
| Sep 22, 2026 | 30.22 | 30.50 | 29.56 | 30.32 | 389.10K |
About ArriVent BioPharma
ArriVent BioPharma (AVBP) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in NEWTOWN SQUARE, PA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1868279.
AVBP board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| John Hohneker | Director | Jun 22, 2026 |
| Stuart Lutzker | President of R&D | Feb 4, 2026 |
| Chris Nolet | Director | Jun 22, 2026 |
| Merdad Parsey | Director | Jun 22, 2026 |
| Kristine Peterson | Director | Jun 22, 2026 |
| Zhengbin Yao | President and CEO | Feb 4, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| James Paul Kastenmayer | General Counsel | Feb 4, 2026 |
| Winston Kung | Chief Financial Officer | Feb 4, 2026 |
| Robin Lachapelle | Chief Operating Officer | Feb 4, 2026 |
| Stuart Lutzker | President of R&D | Feb 4, 2026 |
| Zhengbin Yao | President and CEO | Feb 4, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Dec 10, 2025 | Advisors, Ltd. Hhlr | Sale | 555,555 | $23.37 |
| Dec 10, 2025 | Advisors, Ltd. Hhlr | Sale | 555,555 | $23.37 |
| Dec 10, 2025 | Investment Management, Ltd. Hillhouse | Sale | 555,555 | $23.37 |
| Dec 10, 2025 | Investment Management, Ltd. Hillhouse | Sale | 555,555 | $23.37 |
| Dec 10, 2025 | Advisors, Ltd. Hhlr | Sale | 555,555 | $23.37 |
| Dec 10, 2025 | Advisors, Ltd. Hhlr | Sale | 555,555 | $23.37 |
| Dec 10, 2025 | Investment Management, Ltd. Hillhouse | Sale | 555,555 | $23.37 |
| Dec 10, 2025 | Investment Management, Ltd. Hillhouse | Sale | 555,555 | $23.37 |
AVBP financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-166.31M | -4.32 | $-160.59M |
| Dec 31, 2024 | — | $-80.49M | -2.56 | $-70.21M |
| Dec 31, 2023 | — | $-69.33M | -32.38 | $-55.84M |
Latest balance sheet: total assets $394.72M, total liabilities $27.88M, cash $154.68M (as of Jun 30, 2026).
AVBP earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 12, 2026 | 8-K Item 2.02 (results) | $31.46 |
| May 11, 2026 | 8-K Item 2.02 (results) | $29.02 |
| Mar 5, 2026 | 8-K Item 2.02 (results) | $25.25 |
| Nov 10, 2025 | 8-K Item 2.02 (results) | $18.60 |
| Aug 11, 2025 | 8-K Item 2.02 (results) | $17.39 |
| May 12, 2025 | 8-K Item 2.02 (results) | $19.99 |
| Mar 3, 2025 | 8-K Item 2.02 (results) | $22.03 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $28.08 |
| Aug 14, 2024 | 8-K Item 2.02 (results) | — |
| May 8, 2024 | 8-K Item 2.02 (results) | — |
| Mar 28, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)Novo Nordisk A S (NVO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Tesla (TSLA)Space Exploration Technologies (SPCX)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on AVBP
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 19, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.